RedHill Biopharma reported $990K in Gross Profit on Sales for its fiscal quarter ending in June of 2023.

Gross Profit On Sales Change Date
Compugen USD 6.52M 6.52M Dec/2022
RedHill Biopharma USD 990K 997K Jun/2023